Mirapex ER
Mirapex ER is an extended-release, once-daily formulation of pramipexole, a non-ergoline dopamine agonist. It works by stimulating dopamine receptors in the brain to help control body movements, muscle stiffness, and tremors associated with Parkinson's disease.
Dosage by Body Weight
Take orally once daily, with or without food. Tablets must be swallowed whole and should not be chewed, crushed, or divided. The typical starting dose is 0.375 mg once daily, titrated gradually at intervals of 5 to 7 days up to a maximum dose of 4.5 mg once daily, depending on individual efficacy and tolerability. Dosage adjustment is required for patients with moderate to severe renal impairment.
- Body Weight
- Below 5 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition.
- Body Weight
- 5-7 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition.
- Body Weight
- 8-10 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition.
- Body Weight
- 11-15 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition.
- Body Weight
- 16-20 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not indicated | N/A | Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition. |
| 5-7 kg | Not indicated | N/A | Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition. |
| 8-10 kg | Not indicated | N/A | Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition. |
| 11-15 kg | Not indicated | N/A | Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition. |
| 16-20 kg | Not indicated | N/A | Safety and effectiveness of Mirapex ER in pediatric patients have not been established. Parkinson's disease is an adult onset condition. |
Formulation
Purpose
Treatment of the signs and symptoms of idiopathic Parkinson's disease
Generic Name
Pramipexole dihydrochlorideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.